Uses of immunoconjugates targeting cd138

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 47/48 (2006.01) A61P 35/00 (2006.01)

Patent

CA 2761120

Disclosed are methods and treatment regimes that include the administration of immunconjugates targeting CD138 to combat diseases. The immunoconjugate is either used as the sole active ingredient, as part of a treatment regime or as part of an anticancer combination.

Cette invention concerne des méthodes et des schémas thérapeutiques consistant à administrer des immunoconjugués ciblant l'antigène CD138 pour lutter contre les maladies. L'immunoconjugué peut être utilisé comme principe actif unique, faire partie d'un schéma thérapeutique ou d'un protocole de polychimiothérapie antinéoplasique.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Uses of immunoconjugates targeting cd138 does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Uses of immunoconjugates targeting cd138, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Uses of immunoconjugates targeting cd138 will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-2040420

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.